Thus, galectin-12, resistin, leptin, and other adipokines/cytokines regulated by PPARγ may act synergistically to affect lipid metabolism in metabolic tissues, contributing to the dyslipidemia associated with APL. Here, PPARG is linked to metabolic syndrome.